期刊文献+

肿瘤坏死因子受体超家族成员在免疫系统和疾病中的研究 被引量:12

Research on Tumor Necrosis Factor Receptor Superfamily Members in the Immune System and Diseases
在线阅读 下载PDF
导出
摘要 肿瘤坏死因子受体超家族(tumor necrosis factor receptor superfamily,TNFRSF)是细胞因子受体的一个蛋白质超家族,其显著特征是通过细胞外富含半胱氨酸结构域结合肿瘤坏死因子(tumor necrosis factor,TNF)。肿瘤坏死因子受体(tumor necrosis factor receptors,TNFRs)是古老的细胞因子,TNFRs同源基因最早可追溯到节肢动物果蝇中。TNFRs在炎症反应、细胞凋亡、淋巴细胞稳态和组织发育中发挥重要的作用,TNFRs最主要的功能是与免疫系统相关。鉴于其在免疫系统中发挥重要的作用,肿瘤坏死因子受体家族成员已成为治疗糖尿病、动脉粥样硬化、骨质疏松、自身免疫性疾病、移植排斥反应和癌症等人类疾病的靶点。随着科学技术发展,关于TNFRs的功能有了新的进展,在无脊椎动物和低等脊椎动物中已经有大量报道。在本篇综述中,主要总结了在高等哺乳动物中发现的29种TNFR成员的相关报道,包括8种死亡受体和21种非死亡受体,主要涉及在免疫系统以及与疾病相关领域的研究。大多数研究处于基础实验阶段,少数走向临床研究的案例取得的临床效果并不理想,靶向设计针对自身免疫性疾病、炎症和肿瘤疾病的治疗方案需要更深入的理解TNFRs功能。本文旨在对TNFRs成员发挥的功能有进一步的认识。 The tumor necrosis factor receptor superfamily(TNFRSF)is a protein superfamily of cytokine receptors characterized by the ability to bind tumor necrosis factors(TNFs)via an extracellular cysteine-rich domain.Tumor necrosis factor receptors(TNFRs)are ancient cytokines,and the homologous genes of TNFRs can be traced back to arthropod fruit flies.TNFRs play an important role in inflammatory responses,apoptosis,lymphocyte homeostasis and tissue development.The most important function of TNFR is related to the immune system.In view of their functions,TNFR gene members have been targeted for the treatment of human diseases,such as diabetes,atherosclerosis,osteoporosis,autoimmune diseases,allograft rejection and cancer.With the development of science and technology,new progresses have been made in the function of TNFRs,which have been widely reported in invertebrates and lower vertebrates.In this review,we summarize the reports of 29 TNFR members found in higher mammals,including 8 death receptors and 21 non-death receptors,and the research of immune system and disease-related fields are mainly discussed.Most of the studies are in the basic experimental stage,and a small amount of researches that have entered the clinical stage have not achieved satisfactory results.A deeper understanding of the functions of TNFRs is needed for targeted design treatment for autoimmune diseases,inflammation and tumor diseases.This article aims to gain a better understanding of the functions of TNFR members.
作者 朱医高 逄越 李庆伟 ZHU Yi-Gao;PANG Yue;LI Qing-Wei(College of Life Sciences,Liaoning Normal University,Dalian 116081,Liaoning,China;Lamprey Research Center,Liaoning Normal University,Dalian 116081,Liaoning,China)
出处 《中国生物化学与分子生物学报》 CAS CSCD 北大核心 2020年第2期141-151,共11页 Chinese Journal of Biochemistry and Molecular Biology
基金 国家重大基础研究发展规划(973计划,No.2013CB835304) 国家自然科学基金项目(No.31772884) 全国海洋公益项目(No.201305016) 辽宁省海洋与渔业厅科研项目(No.201805) 大连市科技创新基金项目(No.2018J12SN079)共同资助。
关键词 肿瘤坏因子受体 免疫功能 疾病 tumor necrosis factor receptors immune functions diseases
作者简介 通讯作者:逄越,Tel:0411-85827099,E-mail:pangyue01@163.com;通讯作者:李庆伟,Tel:0411-85827799,E-mail:liqw@263.net
  • 相关文献

参考文献3

二级参考文献15

  • 1Okamot K, Okazawa H, Okuda A, et al. A novel octamer binding transcription factor is differentially expressed in mouse embryonic cells. Cell, 1990, 60:461472.
  • 2Rosner MH, Vigano MA, Ozato K, et al. A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo. Nature, 1990, 345:686-692.
  • 3Hansis C, Grifo JA, Krey LC. Oct-4 expression in inner cell mass and trophectoderm of human blastocysts. Mol Hum Reprod, 2000,6:999-1004.
  • 4Jones TD, Ulbright TM, Eble JN, et al. OCT4 staining in testicular tumors:a sensitive and specific marker for seminoma and embryonal carcinoma. Am J Surg Pathol, 2004, 28:935-940.
  • 5Cheng L, Thomas A, Roth LM, et al. OCT4, A novel biomarker for dysgerminoma of the ovary. Am J Surg Pathol, 2004, 28: 1341-1346.
  • 6Hattab EM, Tu PH, Wilson JD, et al. OCT4 immunohistochemistry is superior to placental alkaline phosphatase (PLAP) in the diagnosis of central nervous system germinoma. Am J Surg Pathol, 2005, 29:368-371.
  • 7Looijenga LH, Stoop H, de Leeuw HP, et al. POUSF1 (0CT3/4)identifies cells with plufipotent potential in human germ cell tumors.Cancer Res, 2003, 63:2244-2250.
  • 8Rosai J. Ackerman's surgical pathology. 8th ed. St. Louis: Mosby,1996. 1495.
  • 9Vliagoftis H, Worobec AS, Metcalfe DD. The protooncogene c-kit and c-kit ligand in human disease. J Allergy Clin Immunol, 1997,100:435 -440.
  • 10Kemmer K, Corless CL, Fletcher JA, et al. KIT mutation are commom in testicular seminomas. Am J Pathol, 2004, 164:305-313.

共引文献27

同被引文献162

引证文献12

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部